Diagnostic accuracy of circulating tumor cells detection in gastric cancer: Systematic review and meta-analysis

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Tang, Lanhua ^a   Zhao, Shushan ^a   Liu, Wei ^a   Parchim, Nicholas F ^b   Huang, Jin ^a   Tang, Youhong ^a   Gan, Pingping ^a   Zhong, Meizuo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Circulating Tumor Cells (CTCs); Diagnostic Accuracy; Gastric Cancer; Meta analysis

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CIRCULATING TUMOR CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; META ANALYSIS; NON INVASIVE PROCEDURE; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SYSTEMATIC REVIEW;

AREA UNDER CURVE; CONFIDENCE INTERVALS; HUMANS; LIKELIHOOD FUNCTIONS; NEOPLASTIC CELLS, CIRCULATING; ODDS RATIO; ROC CURVE; STOMACH NEOPLASMS;

EID: 84879457033     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-314     Document Type: Article

References (55)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917. 10.1002/ijc.25516, 21351269.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
3. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009, 374(9688):477-490. 10.1016/S0140-6736(09)60617-6, 19625077.
4. Lurje G, Schiesser M, Claudius A, Schneider PM. Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol 2010, 2010:392652. 2774472, 19902005.
5. Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pac J Cancer Prev 2008, 9(2):317-321.
6. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005, 241(1):27-39. 1356843, 15621988.
7. Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 1869, 14:146-149.
8. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10(20):6897-6904. 10.1158/1078-0432.CCR-04-0378, 15501967.
9. Saad F, Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol 2012, 8(3):321-331. 10.2217/fon.12.3, 22409467.
10. Mocellin S, Keilholz U, Rossi CR, Nitti D. Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 2006, 12(3):130-139. 10.1016/j.molmed.2006.01.006, 16488189.
11. Msaouel P, Koutsilieris M. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis. BMC Cancer 2011, 11:336. 10.1186/1471-2407-11-336, 3161042, 21816094.
12. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 2000, 156(1):57-63. 10.1016/S0002-9440(10)64706-2, 1868645, 10623654.
13. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 2009, 11(4):883-892. 10.1007/s10544-009-9305-9, 19387837.
14. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 2003, 162:149-155. 10.1007/978-3-642-59349-9_13, 12790329.
15. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450(7173):1235-1239. 10.1038/nature06385, 3090667, 18097410.
16. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 2010, 107(43):18392-18397. 10.1073/pnas.1012539107, 2972993, 20930119.
17. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 2011, 137(8):1151-1173. 10.1007/s00432-011-0988-y, 21681690.
18. Zhe X, Cher ML, Bonfil RD. Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 2011, 1(6):740-751. 3195935, 22016824.
19. Wu CH, Lin SR, Yu FJ, Wu DC, Pan YS, Hsieh JS, Huang SY, Wang JY. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 2006, 119(2):373-379. 10.1002/ijc.21856, 16477642.
20. Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K, Irino T, Yoshikawa T, Matsuda S, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008, 15(11):3092-3100. 10.1245/s10434-008-0122-9, 18766405.
21. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997, 72(3):408-411. 10.1002/(SICI)1097-0215(19970729)72:3<408::AID-IJC6>3.0.CO;2-T, 9247282.
22. Bertazza L, Mocellin S, Marchet A, Pilati P, Gabrieli J, Scalerta R, Nitti D. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 2009, 7:111. 10.1186/1479-5876-7-111, 2807427, 20028510.
23. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008, 149(12):889-897. 10.7326/0003-4819-149-12-200812160-00008, 2956514, 19075208.
24. Barker FG, Carter BS. Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurg Focus 2005, 19(4):E5.
25. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155(8):529-536. 10.7326/0003-4819-155-8-201110180-00009, 22007046.
26. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003, 49(1):1-6. 10.1373/49.1.1, 12507953.
27. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001, 323(7305):157-162. 1120791, 11463691.
28. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56(11):1129-1135. 10.1016/S0895-4356(03)00177-X, 14615004.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
30. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 2010, 29(12):1282-1297.
31. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005, 58(9):882-893. 10.1016/j.jclinepi.2005.01.016, 16085191.
32. Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, Yu X, Xiao B, Wang W, Guo J. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem 2011, 44(13):1050-1057. 10.1016/j.clinbiochem.2011.06.004, 21704610.
33. Ikeguchi M, Ohro S, Maeda Y, Fukuda K, Yamaguchi K, Shirai H, Kondo A, Tsujitani S, Kaibara N. Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med 2003, 11(2):217-221.
34. Ikeguchi M, Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005, 35(6):436-441. 10.1007/s00595-004-2978-z, 15912289.
35. Ito H, Inoue H, Tsujino Y, Sando N, Kimura S, Ozawa T, Masago A, Urata Y, Tanaka J, Kudo S. Detection of circulating tumor cells in gastric cancer patients using telomerase-specific replication-selective adenoviral agent: Prospective feasibility study. Ann Oncol 2010, 21:viii73.
36. Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology 2008, 55(84):1131-1135.
37. Majima T, Ichikura T, Takayama E, Chochi K, Mochizuki H. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for Cytokeratin mRNA in peripheral blood from patients with gastric cancer. Jpn J Clin Oncol 2000, 30(11):499-503. 10.1093/jjco/hyd130, 11155920.
38. Noh YH, Im G, Ku JH, Lee YS, Ahn MJ. Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. J Korean Med Sci 1999, 14(6):623-628. 3054435, 10642939.
39. Qiao SX, Qiao X, Wang WH. Detection of free cancer cell CK-20 mRNA in peripheral blood in patients with gastric carcinoma. Journal of Jilin University Medicine Edition 2007, 33(2):341-343.
40. Ren CL, Han CX, Wang DX, Wang BH, Xu XX, Zhang JX, Zhou L, Wu ZF. A new isolation method for peripheral blood circulating solid tumor cells with EpCAM antibody-linked nanobeads. Chinese Journal of Laboratory Medicine 2011, 34(3):218-223.
41. Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu FJ, Huang TJ, Wang JY. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clinica chimica acta; international journal of clinical chemistry 2006, 367(1-2):55-61.
42. Wang WX, Li YB, Xie XL, Shu XL, Ouyang XH. Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers. Chinese journal of gastrointestinal surgery 2009, 12(6):611-614.
43. Wu CH, Lin SR, Hsieh JS, Chen FM, Lu CY, Yu FJ, Cheng TL, Huang TJ, Huang SY, Wang JY. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers 2006, 22(3):103-109. 10.1155/2006/281315, 16788243.
44. Yang WY, Du ZX, Fan RJ, Liang AL, Xiao CM. Detection of cancer cells in peripheral blood by RT-PCR in gastric cancer predicts micrometastasis. Journal of Hebei Medical Unicersity 2002, 23(3):162-164.
45. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT, Cheng AL. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer. Anticancer Res 1998, 18(2 B):1283-1286.
46. Zhang JP, Zhu CF, Wang KJ, Xu H, Wang SZ, Zhu P, Gao X, Wu WZ. Effect of surgical manipulation on the disseminatin of cancer cells into peripheral blood in patients with gastric cancer and its risk factor analysis. Chinese journal of gastrointestinal surgery 2007, 10(3):234-237.
47. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 2010, 88(7):709-717. 10.1007/s00109-010-0617-2, 20349219.
48. Gerges N, Rak J, Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010, 94:49-64. 10.1093/bmb/ldq011, 20418405.
49. Tsao H, Nadiminti U, Sober AJ, Bigby M. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 2001, 137(3):325-330.
50. Zhang R, Shao F, Wu X, Ying K. Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis. Lung Cancer 2010, 69(2):225-231. 10.1016/j.lungcan.2009.11.009, 20004997.
51. Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW, Foekens JA. Circulating tumour cell detection on its way to routine diagnostic implementation?. Eur J Cancer 2007, 43(18):2645-2650. 10.1016/j.ejca.2007.09.016, 17977713.
52. Mellado B, Colomer D, Castel T, Munoz M, Carballo E, Galan M, Mascaro JM, Vives-Corrons JL, Grau JJ, Estape J. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996, 14(7):2091-2097.
53. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A, et al. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996, 88(9):590-594. 10.1093/jnci/88.9.590, 8609659.
54. Pantel K, Alix-Panabieres C. The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 2007, 4(2):62-63.
55. Wang D, Mou ZY, Zhai JX, Zong HX, Zhao XD. [Application of Stata software to test heterogeneity in meta-analysis method]. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29(7):726-729.